Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IMLYGIC
- Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
- OH2 Administered by Intratumoral Injection
- oHSV2-PD-L1/CD3-BsAb Administered Via Intramural Injection
- Neoadjuvant Combination Immunotherapy for Stage III Melanoma
- Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
- Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
- A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion
- T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With Metastatic, Unresectable, or Locoregionally Recurrent HER2- Negative Breast Cancer
- Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
- Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
- Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma
- Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer
- A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
Clinical trials list
click for details